Two Sigma Investments, LP Amgen Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Amgen Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 358,741 shares of AMGN stock, worth $94.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

358,741

Previous 542,148 33.83%

Holding current value

$94.9 Million

Previous $169 Million 31.76%

% of portfolio

0.27%

Previous 0.41%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $56.7 Million - $61.9 Million	-183,407 Reduced 33.83%	358,741 $116 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $113 Million - $137 Million	429,765 Added 382.41%	542,148 $169 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $4.07 Million - $4.91 Million	15,142 Added 15.57%	112,383 $32 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $158 Million - $178 Million	-618,747 Reduced 86.42%	97,241 $28 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $59.2 Million - $73.5 Million	-270,913 Reduced 27.45%	715,988 $192 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $8.88 Million - $10.5 Million	41,426 Added 4.38%	986,901 $219 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $3.96 Million - $4.82 Million	17,524 Added 1.89%	945,475 $229 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $523,104 - $664,666	-2,284 Reduced 0.25%	927,951 $244 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $28.4 Million - $32 Million	126,402 Added 15.72%	930,235 $210 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $55.7 Million - $62 Million	-241,382 Reduced 23.09%	803,833 $196 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $11.6 Million - $12.8 Million	52,923 Added 5.33%	1,045,215 $253 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $14.4 Million - $16.5 Million	-72,653 Reduced 6.82%	992,292 $223 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $26.5 Million - $31.1 Million	125,064 Added 13.31%	1,064,945 $226 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $218 Million - $242 Million	933,781 Added 15307.89%	939,881 $229 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $69.1 Million - $82.3 Million	-319,450 Reduced 98.13%	6,100 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $36.1 Million - $44.3 Million	182,669 Added 127.85%	325,550 $76.8 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $20.9 Million - $27.7 Million	114,548 Added 404.29%	142,881 $29 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $12.4 Million - $15.9 Million	-65,483 Reduced 69.8%	28,333 $6.83 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $103 Million - $124 Million	-593,662 Reduced 86.35%	93,816 $18.2 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $5.11 Million - $5.99 Million	30,676 Added 4.67%	687,478 $127 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $103 Million - $116 Million	570,716 Added 662.96%	656,802 $125 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $34.7 Million - $40.5 Million	-194,584 Reduced 69.33%	86,086 $16.8 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $57 Million - $64.3 Million	-307,799 Reduced 52.31%	280,670 $58.2 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $63.7 Million - $71.6 Million	383,825 Added 187.56%	588,469 $109 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $62.1 Million - $72.6 Million	-366,739 Reduced 64.18%	204,644 $34.9 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $13.5 Million - $15.1 Million	79,938 Added 16.27%	571,383 $99.4 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $82.2 Million - $93.9 Million	491,445	491,445 $91.6 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Amgen Inc Transaction History